EcoDrugPlus

Ribosomal Protein S9

Ensembl ID : ENSAPEG00000008214
Gene Symbol: RPS9
1 Cross references
237 Possible Orthologues:

Ribosomal Protein, Large, P1

Ensembl ID : ENSAPEG00000004985
Gene Symbol: RPLP1
1 Cross references
386 Possible Orthologues:

Selectin E

Ensembl ID : ENSAPEG00000024111
Gene Symbol: SELE
2 Cross references
181 Possible Orthologues:

Selectin P

Ensembl ID : ENSAPEG00000024129
Gene Symbol: SELP
1 Cross references
170 Possible Orthologues:

Serpin Peptidase Inhibitor, Clade C (Antithrombin), Member 1

Ensembl ID : ENSAPEG00000020299
Gene Symbol: SERPINC1
1 Cross references
202 Possible Orthologues:

Si:dkey-211g8.6

Ensembl ID : ENSAPEG00000020224
Gene Symbol: SI:DKEY-211G8.6
1 Cross references
319 Possible Orthologues:

Si:dkey-91m11.5

Ensembl ID : ENSAPEG00000001963
Gene Symbol: SI:DKEY-91M11.5
1 Cross references
203 Possible Orthologues:

Sirtuin 1

Ensembl ID : ENSAPEG00000024712
Gene Symbol: SIRT1
1 Cross references
157 Possible Orthologues:

Sirtuin 1

Ensembl ID : ENSAPEG00000024694
Gene Symbol: SIRT1
1 Cross references
157 Possible Orthologues:

Smoothened, Frizzled Class Receptor

Ensembl ID : ENSAPEG00000004735
Gene Symbol: SMO
1 Cross references
204 Possible Orthologues:

Sodium Channel, Voltage Gated, Type V-Like, Alpha B

Ensembl ID : ENSAPEG00000001992
Gene Symbol: SCN5LAB
1 Cross references
259 Possible Orthologues:

Sodium Channel, Voltage Gated, Type Xii, Alpha A

Ensembl ID : ENSAPEG00000021441
Gene Symbol: SCN12AA
1 Cross references
245 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).